Alkem Laboratories Ltd. a leading Indian pharmaceutical company, today announced the groundbreaking launch of semaglutide in multiple dose strengths utilizing a single-shot pre-filled syringe...
Novartis has officially received European Commission (EC) approval for Rhapsido® (remibrutinib), marking a historic shift in the management of chronic spontaneous urticaria (CSU). Rhapsido...